324 research outputs found

    Gemcitabine and carboplatin in intensively pretreated patients with metastatic breast cancer

    Get PDF
    Background: Patients with metastatic breast cancer (MBC) are increasingly exposed to anthracyclines and taxanes either during treatment of primary breast cancer or during initial therapy of metastatic disease. The combination of gemcitabine and carboplatin was therefore investigated as an anthracycline- and taxane-free treatment option. Patients and Methods: MBC patients previously treated with chemotherapy were enrolled in a multicenter phase II study. Treatment consisted of gemcitabine (1,000 mg/m(2) i.v. on days 1 and 8) and carboplatin (AUC 4 i.v. on day 1) applied every 3 weeks. Results: Thirty-nine patients were recruited, and a total of 207 treatment cycles were applied with a median of 5 cycles per patient. One complete response and 11 partial responses were observed for an overall response rate of 31% (95% CI: 17-48%). Twelve patients (31%) had stable disease. Median time to progression was 5.3 months (95% CI: 2.6-6.7 months) and median overall survival from start of treatment was 13.2 months (95% CI: 8.7-16.7 months). Grade 3/4 hematological toxicity included leukopenia (59%/5%), thrombo-cytopenia (26%/23%) and anemia (10%/0%). Nonhematological toxicity was rarely severe. Conclusion: Combination chemotherapy with gemcitabine and carboplatin is an effective and generally well-tolerated treatment option for intensively pretreated patients with MBC. Due to a considerable incidence of severe thrombocytopenia it would be reasonable to consider starting gemcitabine at the lower dose level of 800 mg/m(2). Copyright (c) 2008 S. Karger AG, Basel

    An experimental investigation on mass transfer in presence of chemical reactions on a graphite cylinder in crossflow

    Get PDF
    In connection with analyses of hypothetical massive air ingress accidents in HTGR (H\underline{H}igh T\underline{T}emperature G\underline{G}as-Cooled R\underline{R}eactor), in which it is assumed that the air is transported through the hot region of graphite core support posts, experiments on mass transfer and in-pore diffusion with homogeneous and heterogeneous chemical reactions were performed on a graphite cylinder in crossflow. Two BLMR (B\underline{B}oundary L\underline{L}ayer M\underline{M}ass transfer controlled R\underline{R}egime) runs and two runs in an intermediate regime between BLMR and IPDR (I\underline{I}n-P\underline{P}ore-D\underline{D}iffusion controlled R\underline{R}egime) were executed at atmospheric pressures, Reynolds numbers ranging from 533 to 2490, and cylinder temperatures from 848°C to 1120°C. The nuclear grade graphite cylinder having a diameter of 100 mm and a porosity of 21.2 % was corroded in a nitrogen gas flow containing approximately 5 % oxygen. Mean and local mass transfer coefficients and corrosion rates were obtained to examine the influences of the chemical reactions on the mass transfer. As a result it can be concluded that the chemical reactions and small changes in shape do not significantly influence the mass transfer under conditions to be expected in HTGR air ingress accidents and that thus the analogy between heat and mass transfer can be used for safety calculations

    High efficacy and low toxicity of weekly docetaxel given as first-line treatment for metastatic breast cancer

    Get PDF
    Background: Docetaxel is one of the most effective antitumor agents currently available for the treatment of metastatic breast cancer (MBC). This phase II multicenter study prospectively analyzed the efficacy and toxicity of docetaxel given on a weekly schedule as first-line treatment of metastatic breast cancer. Patients and Methods: All patients received docetaxel, 35 mg/m(2) weekly for 6 weeks, followed by 2 weeks of rest. Subsequent cycles ( 3 weeks of treatment, 2 weeks of rest) were given until a maximum of 5 cycles or disease progression. Premedication consisted of 8 mg dexamethasone intravenously 30 min prior to the infusion of docetaxel. Results: Fifty-four patients at a median age of 58 years with previously untreated MBC were included in the study. A median of 10 doses ( median cumulative dose 339 mg/m(2)) was administered ( range: 2 - 18). The overall response rate was 48.1% ( 95% CI: 34 - 61%, intent-to-treat). Median survival was 15.8 months and median time to progression was 5.9 months ( intent-to-treat). Hematological toxicity was mild with absence of neutropenia-related complications. Grade 3 neutropenia was observed in 3.7% of patients and grade 3 and 4 anemia was observed in 5.6 and 1.9% of patients, respectively. Conclusion: The weekly administration of docetaxel is highly efficient and safe as first-line treatment for MBC and may serve as an important treatment option specifically in elderly patients and patients with a reduced performance status. Copyright (C) 2005 S. Karger AG, Basel

    Joint probabilistic data association and smoothing applied to multiple space object tracking

    Get PDF
    A foundational aspect of space domain awareness is the ability to identify and track space objects, including space object discovery and custody. This paper demonstrates the power of combining an efficient multiple hypothesis joint probabilistic data association (MH-JPDA) algorithm with a fixed-interval smoother to simultaneously track multiple space objects. For newly discovered objects, statistical initial orbit determination (SIOD) is possible with a single short optical tracklet, but results in large initial uncertainties. Combining these uncertainties with closely spaced objects can result in highly ambiguous data associations, which can lead to poor state estimates and even filter divergence. This paper invokes MH-JPDA to probabilistically update multiple tracks with multiple simultaneous observations in a sequential filter, while avoiding assigning one-to-one associations. Once sufficient information has been collected, the space objects become uniquely distinguishable among each other. Subsequently, the smoother is applied to achieve improved association of the prior observations. MH-JPDA allows for immediate track formation (using SIOD) and sequential processing of incoming observations, providing statistically rigorous real-time state estimates, whereas smoothing produces a more-refined, higher-confidence overall track estimate at user-defined intervals. This paper demonstrates this approach within the Constrained Admissible Region, Multiple Hypothesis Filter (CAR-MHF) software by tracking a simulated break-up scenario.Jason Stauch, Travis Bessell, Mark Rutten, Jason Baldwin, Moriba Jah and Keric Hil

    Metabolic drift in the aging brain.

    Get PDF
    Brain function is highly dependent upon controlled energy metabolism whose loss heralds cognitive impairments. This is particularly notable in the aged individuals and in age-related neurodegenerative diseases. However, how metabolic homeostasis is disrupted in the aging brain is still poorly understood. Here we performed global, metabolomic and proteomic analyses across different anatomical regions of mouse brain at different stages of its adult lifespan. Interestingly, while severe proteomic imbalance was absent, global-untargeted metabolomics revealed an energymetabolic drift or significant imbalance in core metabolite levels in aged mouse brains. Metabolic imbalance was characterized by compromised cellular energy status (NAD decline, increased AMP/ATP, purine/pyrimidine accumulation) and significantly altered oxidative phosphorylation and nucleotide biosynthesis and degradation. The central energy metabolic drift suggests a failure of the cellular machinery to restore metabostasis (metabolite homeostasis) in the aged brain and therefore an inability to respond properly to external stimuli, likely driving the alterations in signaling activity and thus in neuronal function and communication

    Non-invasive detection of iron deficiency by fluorescence measurement of erythrocyte zinc protoporphyrin in the lip

    Get PDF
    Worldwide, more individuals have iron deficiency than any other health problem. Most of those affected are unaware of their lack of iron, in part because detection of iron deficiency has required a blood sample. Here we report a non-invasive method to optically measure an established indicator of iron status, red blood cell zinc protoporphyrin, in the microcirculation of the lower lip. An optical fibre probe is used to illuminate the lip and acquire fluorescence emission spectra in similar to 1 min. Dual-wavelength excitation with spectral fitting is used to distinguish the faint zinc protoporphyrin fluorescence from the much greater tissue background fluorescence, providing immediate results. In 56 women, 35 of whom were iron-deficient, the sensitivity and specificity of optical non-invasive detection of iron deficiency were 97% and 90%, respectively. This fluorescence method potentially provides a rapid, easy to use means for point-of-care screening for iron deficiency in resource-limited settings lacking laboratory infrastructure

    Non-invasive detection of iron deficiency by fluorescence measurement of erythrocyte zinc protoporphyrin in the lip

    Get PDF
    Worldwide, more individuals have iron deficiency than any other health problem. Most of those affected are unaware of their lack of iron, in part because detection of iron deficiency has required a blood sample. Here we report a non-invasive method to optically measure an established indicator of iron status, red blood cell zinc protoporphyrin, in the microcirculation of the lower lip. An optical fibre probe is used to illuminate the lip and acquire fluorescence emission spectra in similar to 1 min. Dual-wavelength excitation with spectral fitting is used to distinguish the faint zinc protoporphyrin fluorescence from the much greater tissue background fluorescence, providing immediate results. In 56 women, 35 of whom were iron-deficient, the sensitivity and specificity of optical non-invasive detection of iron deficiency were 97% and 90%, respectively. This fluorescence method potentially provides a rapid, easy to use means for point-of-care screening for iron deficiency in resource-limited settings lacking laboratory infrastructure
    corecore